Ketorolac before surgery for fewer ureteral stent symptoms

You may qualify if

• Over 18 years of age and willing and able to provide informed consent
• Patients with renal urolithiasis planning to undergo ureteral stent placement following ureteroscopic manipulation

You can't join if

• Patients requiring a bilateral stone procedure.
• Patients on a chronic non-steroidal anti-inflammatory drugs (NSAIDs) including Aspirin defined as any NSAIDs use for more than fifteen days within thirty days prior to the procedure. Exception: use of daily Aspirin 81 mg is allowed.
• Patients on any steroid therapy.
• Patients with prescription anti-inflammatory drugs.
• Patients with gastrointestinal ulcers.
• Patients with ureteral obstruction or stricture unrelated to stone disease.
• Patients with active urinary tract infection as evidence of untreated positive urine culture obtained prior to the procedure (as part of pre-operative testing).
• Patients with preexisting indwelling ureteral stent
• Patients who are pregnant or lactating.
• Patients with renal or liver impairment.
• Patients with concurrent disease, infection, or co-morbidity that, in the judgment of the investigator, would render the patient inappropriate for enrollment.